Andrew McNeill
Direktor der Forschung - Eigenkapital bei Cumulus Oncology Ltd.
Profil
Andrew McNeill is an Investor Director at Cumulus Oncology Ltd., an Investor Director at Dxcover Ltd., and a Partner at EOS Syndicate Management Ltd.
He was previously the Chairman at Chromacity Ltd.
from 2017 to 2019.
He received his undergraduate degree from the University of Leeds in 2003.
Aktive Positionen von Andrew McNeill
| Unternehmen | Position | Beginn |
|---|---|---|
EOS Syndicate Management Ltd.
 EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management is an independent venture capital firm founded in 2014 by Kevin Grainger. The firm is headquartered in Scotland, United Kingdom. | Private Equity Investor | - |
Cumulus Oncology Ltd.
 Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Direktor der Forschung - Eigenkapital | - |
Dxcover Ltd.
 Dxcover Ltd. Medical SpecialtiesHealth Technology Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom. | Private Equity Investor | 01.03.2019 |
Ehemalige bekannte Positionen von Andrew McNeill
| Unternehmen | Position | Ende |
|---|---|---|
Chromacity Ltd.
 Chromacity Ltd. Medical SpecialtiesHealth Technology Chromacity Ltd. designs, manufactures and supplies ultrafast fibre lasers. Its products include spark 1040, OPO, FIR and custom systems. The firm’s applications include life sciences, security and defence, environmental sensing and fundamental research. The company was founded by Christopher Leburn, Derryck Reid and Carl Farrell in 2013 and is headquartered in Riccarton, the United Kingdom. | Vorsitzender | 01.11.2019 |
Ausbildung von Andrew McNeill
| University of Leeds | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management is an independent venture capital firm founded in 2014 by Kevin Grainger. The firm is headquartered in Scotland, United Kingdom. | Finance |
Chromacity Ltd.
Chromacity Ltd. Medical SpecialtiesHealth Technology Chromacity Ltd. designs, manufactures and supplies ultrafast fibre lasers. Its products include spark 1040, OPO, FIR and custom systems. The firm’s applications include life sciences, security and defence, environmental sensing and fundamental research. The company was founded by Christopher Leburn, Derryck Reid and Carl Farrell in 2013 and is headquartered in Riccarton, the United Kingdom. | Health Technology |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
Dxcover Ltd.
Dxcover Ltd. Medical SpecialtiesHealth Technology Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom. | Health Technology |
